Applied Pharmacology
Pharmacology · Topic 10
Source: NMC CBME Curriculum 2024 · Volume I · Pharmacology · Topic 10 · combined PDF page 183
Practice questions
- A critically ill patient taking a direct oral anticoagulant develops marked gastrointestinal dysfunction and worsening renal function. Which pharmacological concern is most relevant?
- Which property is a recognized general advantage of direct oral anticoagulants over vitamin K antagonists?
- An ICU patient receiving a DOAC has a substantial increase in volume of distribution during critical illness. Which interpretation best reflects the applied pharmacology concern?
- Which statement best explains why DOAC use in an ICU patient requires attention to the patient's current physiology?
- A ventilated patient is receiving a neuromuscular blocker and appears motionless. Which conclusion is pharmacologically justified?
- Which mechanism most accurately distinguishes succinylcholine from a non-depolarizing neuromuscular blocker?
- A patient in the ICU has prolonged weakness after an extended period of neuromuscular blockade. Which explanation is most consistent with the applied pharmacology review?
- Why may a neuromuscular blocker selected for a critically ill patient require particular caution compared with its use in a healthy perioperative patient?
- A patient with renal impairment requires an echinocandin and is receiving renal replacement therapy. Which statement is best supported by the applied pharmacology review?
- Which echinocandin administration statement is supported by the pharmacokinetic review?
- A patient with severe hepatic impairment is being considered for echinocandin therapy. Which agents does the review specifically advise using with caution?
- What best explains the very low urinary concentrations of echinocandins described in the review?
- A clinician is planning oral treatment with an echinocandin. Which pharmacokinetic fact is most important?
- A patient with chronic pain has inadequate relief with another opioid and intolerable adverse effects. Which statement about methadone is most appropriate?
- Which safety concern is emphasized when methadone is considered for analgesia?
- A patient with chronic pain also has neuropathic pain. Which conclusion is supported by the review of methadone?
- Which statement best characterizes methadone's place in pharmacotherapy?
- Which group of drugs is specifically identified as including approved PPAR-targeting pharmacological agents?
- Which statement best reflects the therapeutic and toxicological roles of PPARs?
- PPARs are best classified pharmacologically as which of the following?
- A proposed PPAR modulator has promising pharmacological activity. What is the most balanced interpretation of the evidence summarized in the review?
- A manufacturer claims that a newer beta blocker must produce better clinical outcomes because it has a different kinetic profile. Which conclusion best fits the reviewed evidence?
- According to the reviewed clinical data, which comparison is most defensible?
- A small, short comparative study reports better tolerability with a newer beta blocker. Which appraisal concern is highlighted by the review?
- Which statement about celiprolol is most consistent with the reviewed evidence?
- When evaluating a promotional claim that a newer beta blocker improves outcomes, which evidence is most important?